by Matthew Johnson | May 1, 2025 | 325(d) issues, Trial Institution
By Levent Herguner and Matt Johnson – In Thermaltake Technology Co., Ltd. et al v. Chien-Hao Chen et al, IPR2024-01230, Paper 12 (PTAB Feb. 19, 2025), the PTAB granted the institution of inter partes review (“IPR”) while an ex parte reexamination (“EPR”) on the...
by Matthew Johnson | Apr 22, 2025 | Time Limits, Trial Institution
By Dalton Earich and Matt Johnson – In 2985 LLC d/b/a Mountain Voyage Company, LLC v. The Ridge Wallet LLC, a Patent Trial and Appeal Board (“PTAB”) panel denied inter partes review (“IPR”) institution where the petition was time barred under 35 U.S.C. § 315(b)...
by Sue Gerber | Apr 18, 2025 | Expert Witnesses, Trial Institution
By Sue Gerber – It is relatively uncommon for parties to submit expert declarations in the preliminary-response phase of an IPR proceeding, but recently the Patent Owner in Imperative Care, Inc. v. Inari Medical, Inc. effectively used that strategy to defeat...
by Matthew Johnson | Apr 3, 2025 | PTAB News, PTAB Trial Basics, Trial Institution
By Joshua Nightingale and Daniel Sloan – Recent developments at the USPTO suggest a significant shift in favor of the PTAB exercising discretionary denial and uncertainty on behalf of parties to PTAB proceedings. On March 24, 2025, following the February 28,...
by Matthew Johnson | Mar 28, 2025 | PTAB News, PTAB Trial Basics, Trial Institution
By Jennifer Chheda, Yi Dulkeith, and Tova Werblowsky – A new interim process for the Director to exercise discretion as to whether to institute an inter partes review(IPR) or a post grant review (PGR) was announced on March 26, 2025, in which discretionary...
by Matthew Johnson | Mar 25, 2025 | PTAB News, Trial Institution
By Matt Johnson – After rescinding the June 2022 guidance regarding Fintiv, the PTAB issued updates to how they will consider discretionary denial issues under Section 314(a) on Monday. The updated guidance states: On February 28, 2025, the USPTO rescinded the...
